source
- New study shows focal therapy matches surgery and radiation survival while reducing side effects in localized prostate cancerPhysicians remain split over focal therapy for localized prostate cancer, a technique that targets MRI‑visible lesions with heat, cold, or other energy sources instead of removing the entire gland.…
- Spruce Biosciences appoints former Zevra Therapeutics CMO Adrian QuartelSpruce Biosciences announced the hiring of Adrian Quartel as its new chief medical officer. Quartel joins Spruce after serving as CMO at Zevra Therapeutics, where he oversaw clinical development.…